BioNTech SE
$86.71
24H
Market Cap
Volume
Supply
Price Chart
About BioNTech SE - BNTX
BioNTech SE is a German biotechnology company that specializes in developing and manufacturing active immunotherapies for a patient-specific approach to the treatment of diseases, notably contributing to the development of mRNA-based vaccines. They gained worldwide recognition for their collaboration with Pfizer in the creation of one of the first widely approved COVID-19 vaccines.
What are BioNTech SE's core values and mission statement?
BioNTech SE's core values center around innovation, scientific excellence, and their commitment to developing transformative medicines for patients. Their mission is to leverage their expertise in the fields of mRNA science and immunotherapy to create novel therapies for cancer and other serious diseases.
Who founded BioNTech SE and when?
BioNTech SE was founded by Uğur Şahin, Özlem Türeci, and Christoph Huber in 2008.
Who leads BioNTech SE?
BioNTech SE is led by Ugur Sahin, who serves as the CEO and co-founder of the company. Dr. Özlem Türeci, also a co-founder, holds the position of Chief Medical Officer.
Where is BioNTech SE located, and what is its base country?
BioNTech SE is headquartered in Mainz, Germany, which is its base country.
On which exchanges is BioNTech SE traded?
BioNTech SE is traded on the Nasdaq Global Select Market under the ticker symbol BNTX and its American Depository Shares are also listed on the Frankfurt Stock Exchange.
Historical data
BioNTech SE (BNTX) Price Live Data
The live price of BioNTech SE (BNTX) is $86.71, with a trading volume of 437,945 in the last 24 hours. Wrapstocks updates the BNTX price in real-time. BioNTech SE is down -1.57% in the last 24 hours. The company has a live market cap of $20,896,241,664.00 and a supply of 240,989,986 BNTX stocks.
BioNTech SE (BNTX) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 1 hour and 53 minutes.
